---
title: "Dongcheng Biochem: Jiangxi Yichun Nuclear Medicine Production Center Commences Operations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248581968.md"
description: "According to the Zhitong Finance APP, Dongcheng Biochem announced that its wholly-owned subsidiary, Jiangxi Andike Pharmaceutical Co., Ltd. (referred to as \"Jiangxi Andike\"), has received the \"Drug GMP Compliance Inspection Result Notification\" issued by the Jiangxi Provincial Drug Administration, adding the Jiangxi Yichun Nuclear Medicine Production Center"
datetime: "2025-07-15T10:09:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248581968.md)
  - [en](https://longbridge.com/en/news/248581968.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248581968.md)
generator: "portal-rs"
---

# Dongcheng Biochem: Jiangxi Yichun Nuclear Medicine Production Center Commences Operations

According to the Zhitong Finance APP, Dongcheng Biochem (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. (referred to as "Jiangxi Andike") received the "Drug GMP Compliance Inspection Result Notification" issued by the Jiangxi Provincial Drug Administration, adding the Jiangxi Yichun Nuclear Medicine Production Center

### Related Stocks

- [002675.CN](https://longbridge.com/en/quote/002675.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Shein Said to Launch IPO This Week, Target Valuation May Be Only USD25B](https://longbridge.com/en/news/296072060.md)
- [OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian](https://longbridge.com/en/news/296607308.md)
- [Lighthouse Canton favors EM high-yield sovereigns as developed-market fiscal risks rise](https://longbridge.com/en/news/296183818.md)
- [Hong Kong billionaire Keswick clan’s Jardine C&C to sell Singapore, Malaysia car dealerships to Indonesian tycoon’s firm](https://longbridge.com/en/news/296664768.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**